← Back to headlines

RNA-Targeted Therapeutics for Lipid Metabolic Disorders: From Bench to Bedside

This story is reported by Science Partner Journals. Read what other outlets are saying below, then open the original report for full details.

RNA-Targeted Therapeutics for Lipid Metabolic Disorders: From Bench to Bedside · NabkaNews